Solubihzation and refolding of bacterial inclusion body proteins

Journal of Bioscience and Bioengineering

Volumn 99, Issue 4, 2005, Pages 303-310

  Singh, Surinder Mohan ^a   Panda, Amulya Kumar ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Aggregation; Human growth hormone; Inclusion body; Native like secondary structure; Protein refolding; Solubilization

Indexed keywords

BACTERIA; CHROMATOGRAPHY; ESCHERICHIA COLI; HORMONES; POLYPEPTIDES; PURIFICATION; SOLUBILITY; UREA;

BIOACTIVE PROTEINS; CHAOTROPIC AGENTS; REFOLDING; SOLUBILIZATION; SOLUBILIZED PROTEINS;

PROTEINS;

BACTERIAL PROTEIN; HUMAN GROWTH HORMONE; ESCHERICHIA COLI PROTEIN; RECOMBINANT PROTEIN;

CELL INCLUSION; ESCHERICHIA COLI; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; SOLUBILIZATION; CELL FRACTIONATION; CHEMISTRY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PROTEIN ENGINEERING; SOLUBILITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

CELL FRACTIONATION; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMAN GROWTH HORMONE; HUMANS; INCLUSION BODIES; PROTEIN DENATURATION; PROTEIN ENGINEERING; PROTEIN FOLDING; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 19644389665     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.99.303     Document Type: Article

References (66)

1. Baneyx, F.: Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol., 10, 411-421 (1999).
2. Swartz, J. R.: Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol., 12, 195-201 (2001).
3. Kane, J. F. and Hartley, D. L.: Formation of recombinant protein inclusion bodies in Escherichia coli. Trends Biotechnol., 6, 95-101 (1988).
4. Fahnert, B., Lile, H., and Neubauer, P.: Inclusion bodies: formation and utilization. Adv. Biochem. Eng./Biotechnol., 89, 93-142 (2004).
5. Rudolph, R. and Lilie, H.: In vitro folding of inclusion body proteins. FASEB J., 10, 49-56 (1996).
6. Vallejo, L. F. and Rinas, U.: Strategy for recovery of active protein through refolding of bacterial inclusion body proteins. Microb. Cell Fact., 3, 2-12 (2004).
7. Clark, E. D.: Refolding of recombinant proteins. Curr. Opin. Biotechnol., 9, 157-163 (1998).
8. Lilie, H., Schwarz, E., and Rudolph, R.: Advances in refolding of proteins produced in E. coli. Curr. Opin. Biotechnol., 9, 497-501 (1998).
9. Fischer, B., Sumner, I., and Goodenough, P.: Isolation, renaturation and formation of disulfide bonds of eukaryotic proteins expressed in E. coli as inclusion bodies. Biotechnol. Bioeng., 41, 3-13 (1993).
10. Rudolph, R., Böhm, G., Lilie, H., and Jaenicke, R.: Folding proteins, p. 57-99. In Creighton, T. E. (ed.), Protein function, a practical approach. IRL-Press, Oxford University Press, Oxford (1997).
11. Dill, K. A. and Shortle, D.: Denatured states of proteins. Annu. Rev. Biochem., 60, 795-825 (1991).
12. Datar, R. V., Cartwright, T., and Rosen, C.G.: Process economics of animal cell and bacterial fermentations: a case study analysis of tissue plasminogen activator. Bio/Technology, 11, 349-357 (1993).
13. Panda, A. K.: Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli. Adv. Biochem. Eng./Biotechnol., 85, 43-93 (2003).
14. Clark, E. D.: Protein refolding for industrial processes. Curr. Opin. Biotechnol., 12, 202-207 (2001).
15. Walsh, G.: Biopharmaceutical benchmarks-2003. Nat. Biotechnol., 21, 865-870 (2003).
16. Bowden, G.A., Paredes, A.M., and Georgiou, G.: Structure and morphology of protein inclusion bodies in Escherichia coli. Bio/Technology, 9, 725-730 (1991).
17. Mitraki, A., Fane, B., Haase-Pettingell, C., Sturtevant, J., and King, J.: Global suppression of protein folding defects and inclusion body formation. Science, 253, 54-58 (1991).
18. Taylor, G., Hoare, M., Gray, D. R., and Marston, F. A. O.: Size and density of protein inclusion bodies. Bio/Technology, 4, 553-557(1986).
19. Georgiou, G. and Valax, P.: Isolating inclusion bodies from bacteria. Methods Enzymol., 309, 48-58 (1999).
20. Carrio, M. M., Cubarsi, R., and Villaverde, A.: Fine architecture of bacterial inclusion bodies. FEBS Lett., 471, 7-11 (2000).
21. Valax, P. and Georgiou, G.: Molecular characterization of β-lactamase inclusion bodies produced in Escherichia coli. 1. Composition. Biotechnol. Prog., 9, 539-547 (1993).
22. Rinas, U. and Baily, J. E.: Protein composition analysis of inclusion bodies produced in recombinant E. coli. Appl. Environ. Microbiol., 59, 561-566 (1992).
23. Carrio, M. M. and Villaverde, A.: Protein aggregation as bacterial inclusion bodies is reversible. FEBS Lett., 489, 29-33 (2001).
24. Carrio, M. M. and Villaverde, A.: Construction and deconstruction of bacterial inclusion bodies. J. Biotechnol., 96, 3-12 (2002).
25. Villaverde, A. and Carrio, M. M.: Protein aggregation in recombinant bacteria: bioloaical role of inclusion bodies. Biotechnol. Lett., 25, 1385-1395 (2003).
26. Betts, S. and King, J.: There's a right way and a wrong way: in vivo and in vitro folding, misfolding and subunit assembly of the P22 tailspike. Struct. Fold. Des., 7, R131-R139 (1999).
27. Kreisberg, J. F., Betts, S.D., Haase-Pettingell, C., and King, J.: The interdigitated beta-helix domain of the P22 tail-spike protein acts as a molecular clamp in trimer stabilization. Protein Sci., 11, 820-830 (2002).
28. Speed, M.A., Wang, D.I., and King, J.: Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat. Biotechnol., 14, 1283-1287 (1996).
29. Fink, A. L.: Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des., 3, R9-R23 (1998).
30. Rajan, R. S., Illing, M. E., Bence, N. F., and Kopito, R. R.: Specificity in intracellular protein aggregation and inclusion body formation. Proc. Natl. Acad. Sci. USA, 98, 13060-13065 (2001).
31. Przybycien, T. M., Dunn, J. P., Valax, P., and Georgiou, G.: Secondary structure characterization of β-lactamase inclusion bodies. Protein Eng., 7, 131-136 (1994).
32. Oberg, K., Chrnnyk, B. A., Wetzel, R., and Fink, A. L.: Native-like secondary structure in interleukin-1 βinclusion bodies by attenuated total reflectance FTIR. Biochemistry, 33, 2628-2634 (1994).
33. Umetsu, M., Tsumoto, K., Ashish, K., Nitta, S., Tanaka, Y., Adschiri, T., and Kumagai, I.: Structural characteristics and refolding of in vivo aggregated hyperthermophilllic archaeon proteins. FEBS Lett., 557, 49-56 (2004).
34. Khan, R. H., AppaRao, K. B. C, Eshwari, A. N. S., Totey, S. M., and Panda, A. K.: Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli. Biotechnol. Prog, 14, 722-728 (1998).
35. Maachupalli-Reddy, J., Kelly, B.D., and De Bernardez Clark, E.: Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme. Biotechnol. Prog., 13, 144-150 (1997).
36. Stockel, J., Doring, K., Malotka, J., Jahnig, F., and Dornmair, K.: Pathway of detergent-mediated and peptide ligand-mediated refolding of heterodimeric class II major histocompatibility complex (MHC) molecules. Eur. J. Biochem., 248, 684-691 (1997).
37. Cardamone, M., Puri, N. K., and Brandon, M. R.: Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies. Biochemistry, 34, 5773-5794 (1995).
38. Burgess, R. R.: Purification of overproduced Escherichia coli RNA polymerase sigma factors by solubilizing inclusion bodies and refolding from sarkosyl. Methods Enzymol., 273, 145-149 (1996).
39. Misawa, S. and Kumagai, I.: Refolding of therapeutic protein produced in Escherichia coli as inclusion bodies. Biopolymers, 51, 297-307 (1999).
40. Mayer, M. and Buchner, J.: Refolding of inclusion body proteins. Methods Mol. Med., 94, 239-254 (2004).
41. Tsumoto, K., Ejima, D., Kumagai, I., and Arakawa, T.: Practical considerations in refolding proteins from inclusion bodies. Protein Expr. Purif., 28, 1-8 (2003).
42. De Bernardez Clark, E., Schwarz, E., and Rudolph, R.: Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol., 309, 217-236 (1999).
43. Yasuda, M., Murakami, Y., Sowa, A., Ogino, H., and Ishikawa, H.: Effect of additives on refolding of a denatured protein. Biotechnol. Prog., 14, 601-606 (1998).
44. Arora, D. and Khanna, N. J.: Method of increasing the yield of properly folded recombinant human gamma Interferon from inclusion bodies. J. Biotechnol., 52, 127-133 (1996).
45. Arakawa, T. and Tsumoto, K.: The effect of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem. Biophys. Res. Commun., 304, 148-152 (2003).
46. Umetsu, M., Tsumoto, K., Hara, M., Ashish, K., Goda, S., Adschiri, T., and Kumagai, I.: How additives influence the refolding of immunoglobulin-folded proteins in a stepwise dialysis system. Spectroscopic evidence for highly efficient refolding of a single-chain Fv fragment. J. Biol. Chem., 278, 8979-8987 (2003).
47. Tsumoto, K., Umetsu, M., Kumagai, I., Ejima, D., Philo, J. S., and Arakawa, T.: Role of arginine in protein refolding, solubilization, and purification. Biotechnol. Prog., 20, 1301-1308 (2004).
48. Middelberg, A. P. J.: Preparative protein folding. Trends Biotechnol., 20, 433-437 (2004).
49. Mark Buswell, A., Ebtinger, M., Vertes, A. A., and Middelberg, A. P.: Effect of operating variables on the yield of recombinant trypsinogen for a pulse-fed dilution-refolding reactor. Biotechnol. Bioeng., 77, 435-444 (2002).
50. Batas, B. and Chaudhuri, J. B.: Protein folding at high concentration using size exclusion chromatography. Biotechnol. Bioeng., 50, 16-23 (1996).
51. Li, M., Su, Z., and Janson, J. C.: In vitro refolding by Chromatographic procedures. Protein Expr. Purif., 33, 1-10 (2004).
52. Katoh, S. and Katoh, Y.: Continuous refolding of lysozyme with fed-batch addition of denatured protein solution. Process Biochem., 35, 1119-1124 (2000).
53. Valejo, L. F. and Rinas, U.: Optimized procedures for renaturation of recombinant human bone morphogenic protein-2 at high protein concentration. Biotechnol. Bioeng., 85, 601-609 (2004).
54. Fahey, E. M., Chaudhuri, J. B., and Binding, P.: Refolding and purification of urokinase plasminogen activator fragment by chromatography. J. Chromatogr. B, 37, 225-235 (2000).
55. Gu, Z., Su, Z., and Janson, J. C.: Urea gradient size exclusion chromatography enhance the yield of lysozyme refolding. J. Chromatogr. A, 918, 311-318 (2001).
56. Schlegl, R., Iberer, G., Machold C., Necina, R., and Jungbauer, A.: Continuous matrix assisted refolding of proteins. J. Chromatogr. A, 1009, 119-132 (2003).
57. Li, M. and Su, Z.: Refolding of superoxide dismutase by ion exchange chromatography. Biotechnol. Lett., 24, 919-923 (2002).
58. Yashimoto, M. and Kubio, R.: Oxidative refolding of denatured/reduced lysozyme utilizing the chaperone-like function of liposomes and immobilized liposome chromatosraphy. Biotechnol. Prog., 15, 480-487 (1999).
59. Altamirano, M. M., Golbik, R., Zahn, R., Buckle, A.M., and Fersht, A. R.: Refolding chromatography with immobilized mini-chaperones. Proc. Natl. Acad. Sci. USA, 94, 3576-3578 (1997).
60. Gao, Y-G., Guan, Y-X., Yao, S-J., and Cho, M-G.: On-column refolding of recombinant human interferon-γ with an immobilized chaperone fragment. Biotechnol. Pros., 19, 915-920 (2003).
61. Patra, A. K., Mukhopadhyay, R., Mukhija, R., Krishnan, A., Garg, L. C., and Panda, A. K.: Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expr. Purif., 18, 182-192 (2000).
62. Puri, N. K., Crivelli, E., Cardamone, M., Fiddes, R., Bertolini, J., Ninham, B., and Brandon, M. R.: Solubilization of growth hormone and other recombinant protein from E. coli inclusion bodies using cationic surfactant. Biochem. J., 285, 871-879 (1992).
63. Tsumoto, K., Umetsu, M., Kumagai, I., Ejima, D., and Arakawa, T.: Solubilization of active green fluorescent protein from insoluble particles by guandine and arginine. Biochem. Biophys. Res. Commun., 312, 1383-1386 (2003).
64. Patra, A. K., Gahlay, G. K., Reddy, B. V. V., Gupta, S. K., and Panda, A. K.: Refolding and structural transition of recombinant bonnet monkey zona pellucida glycoprotein-C expressed in Escherichia coli that binds to spermatozoa. Eur. J. Biochem., 267, 7075-7081 (2000).
65. Raina, K., Panda, A. K., Ali, M. M., and Talwar, G. P.: Purification, refolding and characterization of recombinant LHRH-T multimer. Protein Expr. Purif, 37, 8-17 (2004).
66. Isaksson, O. G., Eden, S., and Jansson, J. O.: Mode of action of pituitary growth hormone on target cells. Annu. Rev. Physiol., 47, 483-499 (1985).